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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine that acts as a neurotransmitter in the central nervous system (CNS) and as an autacoid in the periphery. Serotonin synthesis in the CNS is restricted to serotonergic neurons, which originate from the raphe nuclei of the brain stem and extend vast axonal projections into different areas of the brain and spinal cord. Its synthesis is a two-step reaction. Tryptophan hydroxylase (TPH) 2 catalyzes the first, rate-limiting step in the CNS, in contrast to TPH1, which is active in the periphery. [1] [2] [3] Tph2 is expressed exclusively in serotonergic neurons within the brain and in the enteric nervous system in the gut but not in other peripheral organs or neuronal cell types. [2] [3] [4] [5] [6] Serotonin packaging into vesicles is mediated by vesicular monoamine transporter (VMAT) 2, which is expressed in monoaminergic neurons. 7 Serotonin actions are mediated by its numerous receptors, that have different expression patterns within the CNS, including presynaptic locations. 8, 9 For example, 5-HT1A autoreceptors, which are expressed on soma and dendrites of serotonergic neurons, mediate inhibition of cell firing. 10 Another important component of serotonergic neurons is serotonin transporter (SERT), which mediates 5-HT uptake. 11 In the brain of adult animals, SERT is mainly expressed on 5-HT producing neurons of the raphe nuclei and astrocytes. 12 During development, transient SERT expression in the brain is broader and includes nonserotonergic neurons in limbic, thalamic and retinal areas. 13 Furthermore, SERT is located in a number of peripheral cells, such as platelets, adrenomedullary chromaffin cells, crypt cells in the gut, lung, liver, and testis. 14, 15 SERT expression is therefore not restricted to serotonergic neurons.
Serotonergic neurons of the raphe nuclei are organized in groups, which are distinguished by their different anatomical location, axonal trajectories and physiological properties. [16] [17] [18] The more rostrally located serotonergic cell groups, B6-B9, project to forebrain regions, whereas caudal serotonergic groups, B1-B5, project towards the spinal cord and brain stem. 19 Although anatomically clustered, groups of serotonergic neurons are not homogenous in their electrophysiological properties and consist of different subpopulations, which are not fully characterized so far. 20, 21 During brain development, serotonergic neurons arise from distinct units of the neural tube, named rhombomeres (r1-r3 and r5-r7). 19 Developing 5-HT neuronal precursors along the rhombomeres express the PC12 ETS domain-containing transcription factor 1 (Pet1) and LIM homeobox transcription factor 1 (Lmx1b) which are involved in serotonergic neuron differentiation. Lmx1b precedes Pet1 expression, and is also expressed in dopaminergic progenitors and neurons. 22 Pet1 was thought to be a specific marker of differentiated post-mitotic serotonergic neurons. 16, [23] [24] [25] However, more recent studies indicated that Pet1 is also active in some non-serotonergic cells in adult and developing brain and in peripheral organs such as adrenal glands, the 5-HT-synthesizing enterochromaffin cells of the intestine, developing kidney, and pancreas. 26, 27 The fact that development of serotonergic neurons, 5-HT synthesis, release and reuptake require expression of multiple specific genes was used for the analysis of serotonergic circuits. Mouse models were engineered to express different reporters specifically in serotonergic neurons, such as the transgenic ePet-EYFP 28 , the TPH2-GFP knock-in, 29 and the TPH2-LacZ knock-in mouse lines. 30 These models have been employed in various in vivo and in vitro studies to examine electrophysiological properties and morphology of 5-HT neurons. [28] [29] [30] To manipulate the serotonergic system, various strategies for enhancement or inhibition of neuronal activity have been used. Besides numerous pharmacological interventions, a number of studies employed genetic approaches to inactivate or overexpress different genes involved in serotonergic neuron formation, 5-HT transmission and metabolism. [31] [32] [33] [34] [35] [36] [37] [38] The behavior and physiological consequences of lifelong alterations in serotonergic signaling in the brain in these models were recently reviewed. [39] [40] [41] [42] The characterization of these genetic models contributed greatly to our understanding of serotonergic circuits. However, genetic approaches which result in life-long changes in gene expression (for example full knockouts or constitutive overexpression models) may induce compensatory mechanisms in other neurotransmitter systems, thus making it impossible to assess 5-HT function per se. Moreover, these models do not provide an opportunity to study functions of specific subpopulations of 5-HT neurons. In this review we summarize new tools which provide higher specificity and temporal control to study serotonergic circuitry.
Targeted expression of Cre and Flp recombinases in serotonergic cells
To manipulate serotonergic neurons in the CNS of mice, many studies have made use of the standard Cre-LoxP approach for cell type-specific recombination. The Cre protein is a site-specific DNA recombinase, that catalyses the recombination between two 34 bp long loxP sequences. 43, 44 Cre-dependent recombination in conjunction with LoxP-flanked target genes or stop cassettes can inactivate or activate the expression of a gene of interest (GOI) respectively. Over the last decade, a number of transgenic and knock-in Creexpressing mouse lines have been generated. To direct transgene expression with the same developmental timing and spatial expression patterns as certain endogenous genes, bacterial artificial chromosomes (BACs) have also been widely used. 45 BACs are DNA constructs, which are capable to host the DNA fragments of >350 kilobase pairs with a high degree of stability. 46, 47 Therefore, they are suitable for inserting large promoter regions including distant regulatory elements to drive Cre expression in specific cell populations. 48, 49 Alternatively, knock-in approaches can be applied to control expression of the recombinase using the same machinery which controls expression of cell specific genes. In these cases the expression pattern is much more accurate and does not require time-consuming isolation and characterization of the promoter. 50 Most importantly, the knocked-in transgene does not generate additional mutations at an unknown locus as classical randomly integrated transgenes do. Of note, during the knock-in approach one allele of the gene in which Cre is inserted will be disrupted leading to a heterozygous knockout of this gene unless the transgene is linked via a 2A-peptide sequence at the 3'-end of the endogenous driver gene. For some genes, such as Tph2, the heterozygosity does not evoke behavioral alterations 51 , whereas for other genes, e.g., Sert, the deletion of one allele results in changes in neurochemistry and physiology (see below 2.1.1) and should be considered as an additional factor to be controlled for. Once a specific Cre line is successfully generated, the expression of recombinase can be functionally characterized by crossbreeding with Cre-dependent reporter strains, such as Rosa26loxP-STOP-lacZ or ROSA26loxP-stop-EYFP. 52, 53 which start to express β-Galactosidase (β-Gal) or EYFP, respectively, once Cre recombinase is active. Co-localization analysis of reporter expression and serotonergic markers is an important step in evaluating the specificity and confirming the efficiency of Cre-dependent recombination. In case of inducible Cre-ERT2 models, a chimeric protein consisting of a codon-optimized Cre recombinase fused to a triple mutant form of the human estrogen receptor (ERT2) is expressed in targeted cells. The mutant receptors no longer bind endogenous estradiol, but instead recognize the synthetic ligand Tamoxifen (TMX). Upon TMX administration, the recombinase gains access to the nuclear compartment and initiates recombination, 54 thereby permitting temporal control of gene manipulation.
Another enzyme, flippase (Flp), which works similar to Cre and mediates DNA recombination between 34bp-long Flp recognition target (FRT) sites, has also been used in such approaches (reviewed in 55 ). Available Cre and Flp transgenic mouse lines for the serotonergic system are summarized in Table 1 , and discussed below in more detail. These results indicate a high recombination efficiency and specificity in the raphe of this SERT-Cre mouse line. This line has been widely used for different applications, including studies of heart development, effects of selective serotonin re-uptake inhibitors (SSRIs), sudden infant death syndrome, depression, addiction, development, and metabolism. [56] [57] [58] [59] [60] . Based on the experiments performed in these mice they postulated that leptin regulation of appetite occurs by inhibition of 5-HT synthesis in the brain. However, a detailed analysis by other group could not confirm the expression of LepRb in serotonergic neurons and it was supposed that the phenotypes, observed by Karsenty group were most probably resulting from total instead of conditional LepRb knockout 59 .
Cre recombinase expression driven by the

BAC-SERT-Cre
Three BAC-SERT-Cre transgenic mouse lines were generated in frames of GENSAT project (http://www.gensat.org/index.html). 49 In 2 founder lines (E33/E35) Cre expression was restricted to adult serotonergic neurons, whereas in the third line (E124) Cre expression was also observed in corticothalamic and thalamocortical neurons. 49, 63 Moreover, in the E33 and E124 lines of BAC-SERT-Cre mice, Cre expression was observed in the developing visual system 64 and the upper layers of the barrel cortex, 65 respectively. These findings confirm SERT expression by non-serotonergic neurons during development, as shown earlier. 13, 62 Taken together, BAC-SERT-driven Cre expression targets all serotonergic neurons, however, ectopic SERT expression during development and developmental recombination in transgenic SERT-Cre lines must be considered.
Recombinase expression driven by the Pet1 promoter
ePet1-Cre
Using a 40kb-long DNA region upstream of the Pet1 gene containing an enhancer essential for proper Pet1 expression, the laboratory of E. Deneris generated an ePet1-Cre line which enables Cre-mediated recombination restricted to all 5-HT neurons. 28 Within the CNS, no ePet activity was detected outside the serotonergic system, however the analysis of LacZ expression in the periphery of R26R ePet-Cre mice revealed Cre-dependent recombination in some cells of skin, gut, pancreas, and cardiac neural crest.
ePet-Flpe
A Flp recombinase driver line, ePet-Flpe, was generated in the laboratory of S. Dymecki 66 with the same ePet construct used by the Deneris' group previously to generate the ePetCre line. 28 In the raphe of ePet-Flpe mice, the activity of Flp is high and mediates recombination in most 5-HT raphe neurons. 66
Pet1210-Cre
To control somatic recombination in the Pet1 lineage more reliably, the group of M.
Pasqualetti generated mice expressing Cre under control of a large 210kb-long fragment of the Pet1 genetic locus, including all putative regulatory regions. 26 Pet1210-Cre transgenic mice revealed the existence of non-serotonergic neuronal populations, which express Pet1 within the raphe, mostly in the B8 and B9 cell groups. Cre expression was also detected in embryonic kidney and pancreas, demonstrating that Pet1210-Cre mice are useful to study rather Pet-1 expressing lineages other than 5-HT neurons in particular (Table 1) . Based on these findings, the specificity of other Pet-1 driven Cre lines and reporters, such as ePet1-EYFP, 28 should be reevaluated in these non-serotonergic neuronal populations and peripheral tissues.
BAC-Pet1-Cre
Another BAC-based Pet1-Cre mouse line was generated by the group of Y.Q. 
BAC-Pet1-CreERT2
The same group also generated a BAC-Pet1-CreERT2 transgenic mouse line that allows TMX-inducible recombination. 68 In this model, recombination was shown to be specific for serotonergic neurons in the DR and raphe magnus (RM), but only 85% of TPH2 expressing neurons co-expressed the floxed reporter gene after TMX treatment.
Crossbreeding of this Pet1-CreERT2 line with Lmx1b fl/fl mice led to 40% reductions in brain 5-HT levels and downregulation of serotonergic markers. 68 One limitation of this mouse line is its FVB/N background used for the generation of founder lines. Most floxed mice are generated on a C57BL/6 background, which has become the most widely used strain for developmental and behavioral studies. The FVB/N line was reported to have higher than C57BL/6 mouse line locomotor activity, anxiety, and basal body temperature and is homozygous for the Pde6brd1 allele, causing retinal degradation (http://jaxmice.jax.org/strain/001800.html). As a consequence, most FVB/N mice are blind 69 and thus, not suitable for behavioral experiments. This phenotype might also be inherited after crossing the Pet1-CreERT2 line to other strains and might have an unpredictable impact on experimental results.
Cre recombinase expression driven by the Tph2 promoter 2.3.1. BAC-TPH2-CreERT2
After discovery of the brain specific TPH isoform 6 the Tph2 promoter was used to direct Cre expression selectively to 5-HT neurons. In 2009, the group of D. Bartsch applied a BAC-based transgenic approach to create TMX-inducible TPH2-CreERT2 mice. 70 Besides higher specificity of the Tph2 promoter for serotonergic neurons in comparison to SERT or Pet1, use of CreERT2 in this line allows recombination at any stage of development or adulthood. The same BAC-based construct was also later used to generate a TPH2-CreERT2 rat line. 71 High specificity of Cre expression upon TMX treatment was demonstrated in both TPH2-CreERT2 mouse and rat lines. However, rats showed a lower recombination efficacy compared to mice (77% in rats vs. 90% in mice) ( Table 1 ).
BAC-TPH2-CreERT2
A comparable TPH2-CreERT2 mouse line, based on a BAC construct, was also generated by Yadav and colleagues 72 to study leptin-dependent 5-HT control of appetite.
Characterization of this line after breeding with Rosa26loxP-STOP-lacZ mice 52 and TMX treatment revealed β-Gal staining in DR, median raphe (MnR), and caudal raphe (CR) nuclei of the brainstem but not in hypothalamic or other regions. The specificity for serotonergic neurons within these areas has not been determined however.
BAC-TPH2-iCreERT2
A similar mouse line (TPH2-iCreERT2) was independently generated by B. Gloss, (http://jaxmice.jax.org/strain/016584.html). However in this case, an improved version of Cre gene (iCre) was employed by applying mammalian codon usage and by lowering the high CpG content of the prokaryotic coding sequence, thereby reducing the chances of epigenetic silencing in mammals. 73, 74 We have confirmed iCreERT2-mediated recombination within the DR, but not in the other brain regions using crossbreeding of this mouse line to Rosa26loxP-STOP-lacZ, 52
ROSA26loxP-stop-EYFP, 53 and Rosa26loxP-STOP-tdTomato (Jackson Laboratories, B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J Stock Number: 007914) reporter mice (Fig.1 A, B, C) . Moreover, injection of an adeno associated virus (AAV), EF1a-DIO-CheTA-EYFP, into the medial DR indicated effective Cre-mediated recombination in TPH2-iCreERT2 mice (Fig.1D ). However, a more detailed analysis of the specificity and efficacy of Cre expression in this line is still pending.
In summary, a wide repertoire of genetic tools to target Cre-mediated recombination to serotonergic neurons is now available (Table 1) . Pet1-Cre and SERT-Cre lines are well characterized and represent useful tools to study the serotonergic system, whereby Sertdriven Cre lines have higher specificity and recombination efficiency than Pet1-driven transgenes, as recently demonstrated in the comparative study of VMAT Sert-Cre and VMAT Pet1-Cre mice. 75 However, both promoters are not exclusively selective for the serotonergic lineage, whereas Tph2-driven Cre expression represents a more specific tool and should be regarded as a better model to target 5-HT-producing neurons specifically in the future. Additionally, the recent availability of the Tph2-driven rat Cre line 71 allowed researchers to apply the more sophisticated behavioral tests for higher cognitive functions that have been already developed for use in rats, but not in mice.
Targeting defined serotonergic subpopulations
As described in the sections above, precise targeting of a transgene to most serotonergic neurons can be performed successfully using several different mouse lines, albeit with some limitations. However, the serotonergic system itself is heterogeneous and includes various subpopulations of neurons with different connectivity, functions, and developmental origins. Manipulating these subpopulations selectively requires more advanced methods. 
Dual recombinase strategies
Viral mediated gene transfer
An alternative to transgenic approaches is virus-mediated gene transfer into specific brain structures. Spatial control of vector delivery can be achieved by using the appropriate stereotaxic injection coordinates.
Adenoviruses were among the first viruses to be successfully used for the specific infection of DR. 78 In this approach, stereotaxic injection of a Cre-expressing adenovirus Lentiviruses have also been applied to label serotonergic neurons. To drive the expression of the EGFP exclusively in serotonergic neurons, an optimized Tph2 promoter with a twostep transcriptional amplification design was employed. 81 Stereotactic injections of such viruses to medulla oblongata covering some of the midline and ventral raphe led to EGFP expression that was 97% colocalized with TPH expression. Of particular importance is the ability of lentiviruses to stably integrate into the genome of non-dividing cells, which is useful for lineage tracing.
Meanwhile more advanced techniques combining AAV and transgenic approaches have been developed to enable highly selective transgene expression. For example, by injecting a double-floxed AAV with an inverse open reading frame for a channelrhodopsin2-mCherry fusion protein (AAV2 DIO ChR2-mCherry) into the raphe obscurus (RO) of ePetCre mice, DePuy and colleagues showed that roughly half of 5-HT neurons in the raphe area were infected and 97% of infected cells were serotonergic. 82 Recently, sindbis virus, canine adenovirus serotype 2 (CAV2), and rabies viruses have been developed for anterograde, retrograde, and transsynaptic retrograde transport, respectively, and used to study serotonergic circuitry. [83] [84] [85] [86] [87] [88] [89] [90] 
Anterograde transport
Suzuki et al. injected a GFP-tagged sindbis virus into the DR for anterograde tracing of single serotonergic neurons to the olfactory bulb. 87 The advantage of using sindbis virus is its high transfection efficiency in the CNS and its capacity to carry large amounts of genetic material. However, this virus is suitable only for acute in vivo work as infected neurons start degenerating 7 days after viral injection. 91 
Retrograde transport
Transsynaptic transport
To analyze monosynaptic inputs to DR and MnR serotonergic neurons, Ogawa and colleagues used a retrograde transsynaptic system based on a modified rabies virus that initially infects only cognate receptor (TVA protein) expressing cells and lacks a glycoprotein required for transsynaptic spread. 83 SERT-Cre mice 50 were injected with two helper viruses expressing the glycoprotein and TVA after Cre recombination into either DR or MnR. 88 This allowed the virus to spread transsynaptically to cells with direct synaptic contact to DR or MnR serotonergic neurons. Here, 95.8 % of infected TVA expressing cells were shown to be serotonergic and 30.5 % of 5-HT neurons were infected and expressed TVA. A small number of neighboring 5-HT-containing neurons were targeted as well. 83 A rabies virus tracing strategy in SERT-Cre mice was also used in other studies to generate a whole-brain atlas of putative monosynaptic inputs onto forebrain-projecting DR and MnR serotonergic neurons or to characterize the distinct excitatory, inhibitory, and peptidergic inputs to the DR. 84, 86, 89 However, released rabies virus can be taken up by adjacent terminals that may or may not be synaptically connected. 92 Classification of connectivity patterns will permit further functional dissection of the serotonergic system and enable analysis of the physiological relevance of specific input circuits. 
Temporal control of gene expression within the serotonergic system
Inducible Cre-expressing mouse lines
Performing a genetic manipulation at a selected time point during the lifetime allows the study of age-specific biochemical and behavioral effects within the serotonergic system.
Several inducible Cre lines that enable excision or activation of genes at chosen time points within the serotonergic system are described in the sections above 49, 68, 70, 71, 100 and are summarized in Table 1 However, Ptet-controlled gene expression after Dox withdrawal occurs with a delay, depending on the animal's age, Dox concentration, duration of treatment, and many other factors that have to be controlled for. In contrast to i.p. administration of TMX, Dox treatment is more suitable for behavior studies as it can be added to the drinking water diminishing effect of stress. Since Dox has a bitter taste, sugar or sweeteners are often added to Dox solutions that may lead to an increase in drinking volume, additional body weight gain, or other unexpected behavioral outcomes. To study the influence of serotonergic activity on homeostatic control, Di was expressed via previously described dual-recombinase methodology with cell-subtype precision. 66, 77, with SERT-Cre was used to express Di in nearly all serotonergic neurons. These cells responded to CNO with hyperpolarization that led to the suppression of cell excitability. 
Tetracycline-sensitive systems
DREADDs
Optogenetics
Optogenetics is another current technique to modulate neuronal function that does not involve chemical ligands and enables much higher temporal resolution. 115 Optogenetics enables researchers to manipulate firing rates of specific neuronal populations and to measure the outcome using physiological and behavioral readouts in vivo. For tight optical control of neuronal excitability, light-sensitive channels or light-driven ion pumps are expressed in genetically defined neurons. The most commonly used optogenetic actuator is the non-selective cation channel channelrhodopsin, ChR2, and its derivatives. Using have opposing effects on the nociceptive control so as to cancel each other out.
To refine the spatial specificity, mouse lines expressing Cre recombinase under cellspecific promoters, in combination with viral delivery can also be used for optogenetic experiments. Such an approach was used in the study by Dugue et al., where viral vectors were injected into transgenic SERT-Cre mice (described above). 127 In this study, response thresholds in awake behaving SERT-Cre mice following injection of viruses carrying Credependent ChR2-EYFP into the DR (coordinates from bregma: 0 mm ML, 4.4 to -4.7 mm AP, -2.8 to -2.9 mm DV, with a 34 0 caudal angle) were higher compared to control mice in the von Frey assay, a simple test of mechanosensitivity. 128 The work of Dugue et al. 127 and our studies (Fig. 2B-D) show that the response might differ between anesthetized and conscious animals, and that the roles of different serotonergic subpopulations may not be identical.
Delivery of light-sensitive channels is possible by combining the above described mouse [133] [134] [135] [136] will help to overcome these concerns.
The techniques discussed in this section allow manipulations of specific neuronal populations in freely behaving animals with improved spatial and temporal precision.
Optogenetics and DREADDs both involve the introduction of non-native proteins into neurons that thereby respond to defined stimuli (light or CNO) with altered excitability. For the analysis of temporal dynamics of specific circuits, optogenetics must be used, whereby an optical fiber needs to be implanted and manipulations can only affect the illuminated area in the brain. In contrast, by a simple systemic CNO administration all DREADDs distributed within large tissue volumes can be stimulated simultaneously. Likewise, the tetOff system allows gene expression control in all tissues expressing the chosen promotor.
In all cases, unknown side effects of chemical agent administration or blue light have to be considered. 101, 102, 131, 132, [137] [138] [139] 
Summary
Serotonergic neurons in the raphe nuclei give rise to a complex and extensive network of axonal projections throughout the whole brain. A major challenge in the analysis of these circuits is to understand how the serotonergic networks are linked to the numerous functions of this neurotransmitter. 
